Neurocrine Biosciences, Inc.
NASDAQ:NBIX
122.25 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,887.1 | 1,488.7 | 1,133.5 | 1,045.9 | 788.1 | 451.24 | 161.626 | 15 | 19.769 | 0 | 2.919 | 53.14 | 77.413 | 33.501 | 2.953 | 3.975 | 1.224 | 39.234 | 123.889 | 85.176 | 139.078 | 18.045 | 41.242 | 14.588 | 16.8 | 16 | 26.1 | 19.2 |
| Cost of Revenue
| 39.7 | 23.2 | 14.3 | 10.1 | 7.4 | 4.889 | 1.254 | 35.9 | 33.8 | 14.4 | 13.8 | 11.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.198 | -2.1 | -1.7 | -1.3 | -1 |
| Gross Profit
| 1,847.4 | 1,465.5 | 1,119.2 | 1,035.8 | 780.7 | 446.351 | 160.372 | -20.9 | -14.031 | -14.4 | -10.881 | 41.54 | 77.413 | 33.501 | 2.953 | 3.975 | 1.224 | 39.234 | 123.889 | 85.176 | 139.078 | 18.045 | 41.242 | 16.786 | 18.9 | 17.7 | 27.4 | 20.2 |
| Gross Profit Ratio
| 0.979 | 0.984 | 0.987 | 0.99 | 0.991 | 0.989 | 0.992 | -1.393 | -0.71 | 0 | -3.728 | 0.782 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.151 | 1.125 | 1.106 | 1.05 | 1.052 |
| Reseach & Development Expenses
| 565 | 463.8 | 328.1 | 275 | 200 | 160.524 | 121.827 | 94.291 | 81.491 | 46.425 | 39.248 | 37.163 | 30.951 | 31.151 | 35.81 | 55.291 | 81.985 | 97.678 | 106.628 | 115.066 | 177.271 | 108.939 | 74.267 | 40.227 | 29.2 | 21.8 | 19.9 | 12.6 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 248.932 | 169.906 | 68.081 | 32.48 | 17.986 | 13.349 | 13.437 | 12.54 | 16.072 | 14.829 | 20.24 | 37.481 | 54.873 | 42.333 | 22.444 | 20.594 | 12.721 | 10.857 | 9.962 | 7.5 | 6.6 | 5.7 | 3.7 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.082 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 887.6 | 752.7 | 583.3 | 433.3 | 354.1 | 248.932 | 169.906 | 68.081 | 32.48 | 17.986 | 13.349 | 13.437 | 12.458 | 16.072 | 14.829 | 20.24 | 37.481 | 54.873 | 42.333 | 22.444 | 20.594 | 12.721 | 10.857 | 9.962 | 7.5 | 6.6 | 5.7 | 3.7 |
| Other Expenses
| 143.9 | 0 | 105.3 | 164.5 | 154.272 | 0 | -0.02 | 0.013 | 0.011 | 0.018 | 0.016 | 0.014 | 42.229 | 73.29 | 70.986 | 15.742 | 94 | 90.962 | 97.441 | 87.91 | 80.572 | 96.575 | 0 | 2.198 | 2.1 | 1.7 | 1.3 | 1 |
| Operating Expenses
| 1,452.6 | 1,216.5 | 911.4 | 708.3 | 554.1 | 409.456 | 291.733 | 162.372 | 113.971 | 64.411 | 52.597 | 51.692 | 43.409 | 47.223 | 50.639 | 91.273 | 213.466 | 152.551 | 148.961 | 137.51 | 197.865 | 121.66 | 85.124 | 52.387 | 38.8 | 30.1 | 26.9 | 17.3 |
| Operating Income
| 250.9 | 249 | 196.9 | 318.9 | 219.148 | 36.895 | -131.361 | -147.372 | -94.202 | -64.411 | -49.678 | 1.448 | 33.922 | -13.722 | -53.67 | -87.298 | -212.242 | -113.317 | -25.072 | -52.334 | -58.787 | -103.615 | -43.882 | -35.601 | -19.9 | -12.4 | 0.5 | 2.9 |
| Operating Income Ratio
| 0.133 | 0.167 | 0.174 | 0.305 | 0.278 | 0.082 | -0.813 | -9.825 | -4.765 | 0 | -17.019 | 0.027 | 0.438 | -0.41 | -18.175 | -21.962 | -173.4 | -2.888 | -0.202 | -0.614 | -0.423 | -5.742 | -1.064 | -2.44 | -1.185 | -0.775 | 0.019 | 0.151 |
| Total Other Income Expenses Net
| -58.1 | -35.1 | -95.5 | -212.2 | -172.648 | 15.476 | 8.342 | 6.282 | 5.273 | 3.869 | 3.588 | 3.577 | 3.567 | 5.754 | -3.352 | -14.071 | -94 | 6.112 | 2.881 | -0.135 | 18.088 | 0.215 | 0.43 | 1.047 | 0.2 | -7.4 | 4.9 | 3.4 |
| Income Before Tax
| 332.1 | 213.9 | 101.4 | 106.7 | 46.5 | 21.841 | -142.542 | -141.09 | -88.929 | -60.542 | -46.09 | 5.025 | 37.571 | -7.968 | -88.613 | -88.613 | -207.299 | -107.205 | -22.191 | -45.694 | -30.098 | -94.536 | -36.79 | -28.506 | -19.7 | -19.8 | 5.3 | 6.1 |
| Income Before Tax Ratio
| 0.176 | 0.144 | 0.089 | 0.102 | 0.059 | 0.048 | -0.882 | -9.406 | -4.498 | 0 | -15.79 | 0.095 | 0.485 | -0.238 | -30.008 | -22.293 | -169.362 | -2.732 | -0.179 | -0.536 | -0.216 | -5.239 | -0.892 | -1.954 | -1.173 | -1.238 | 0.203 | 0.318 |
| Income Tax Expense
| 82.4 | 59.4 | 11.8 | -300.6 | 9.5 | 0.73 | 17.103 | -7.722 | -6.271 | -4.678 | -4.243 | -4.22 | -4.261 | 0 | 0.173 | 1.315 | -4.943 | 0 | 0 | 0.079 | 0.158 | -9.079 | 0.12 | 0.302 | -3.1 | 7.6 | 0.2 | 0.2 |
| Net Income
| 249.7 | 154.5 | 89.6 | 407.3 | 37 | 21.111 | -142.542 | -141.09 | -88.929 | -60.542 | -46.09 | 5.025 | 37.571 | -7.968 | -51.038 | -88.613 | -207.299 | -107.205 | -22.191 | -45.773 | -30.256 | -94.536 | -36.91 | -28.808 | -16.8 | -20 | 5.1 | 5.9 |
| Net Income Ratio
| 0.132 | 0.104 | 0.079 | 0.389 | 0.047 | 0.047 | -0.882 | -9.406 | -4.498 | 0 | -15.79 | 0.095 | 0.485 | -0.238 | -17.283 | -22.293 | -169.362 | -2.732 | -0.179 | -0.537 | -0.218 | -5.239 | -0.895 | -1.975 | -1 | -1.25 | 0.195 | 0.307 |
| EPS
| 2.56 | 1.61 | 0.95 | 4.37 | 0.4 | 0.22 | -1.62 | -1.63 | -1.05 | -0.81 | -0.69 | 0.077 | 0.68 | -0.15 | -1.3 | -2.3 | -5.45 | -2.84 | -0.6 | -1.26 | -0.93 | -3.1 | -1.42 | -1.3 | -0.88 | -1.1 | 0.3 | 0.39 |
| EPS Diluted
| 2.47 | 1.56 | 0.92 | 4.16 | 0.39 | 0.22 | -1.62 | -1.63 | -1.05 | -0.81 | -0.69 | 0.075 | 0.67 | -0.15 | -1.3 | -2.3 | -5.45 | -2.84 | -0.58 | -1.26 | -0.93 | -3.1 | -1.42 | -1.3 | -0.88 | -1.1 | 0.28 | 0.36 |
| EBITDA
| 416.1 | 249 | 207.8 | 327.5 | 226.6 | 36.895 | -131.381 | -153.641 | -99.464 | -68.262 | -53.25 | -2.115 | 30.437 | -12.286 | -44.334 | -65.617 | -108.838 | -102.751 | -14.978 | -45.118 | -73.183 | -100.732 | -41.661 | -34.45 | -18 | -3.3 | -3.1 | 0.5 |
| EBITDA Ratio
| 0.22 | 0.167 | 0.183 | 0.313 | 0.288 | 0.082 | -0.813 | -10.243 | -5.031 | 0 | -18.243 | -0.04 | 0.393 | -0.367 | -15.013 | -16.507 | -88.92 | -2.619 | -0.121 | -0.53 | -0.526 | -5.582 | -1.01 | -2.362 | -1.071 | -0.206 | -0.119 | 0.026 |